ContraFect Corporation Gains 52.9%
Mon, Feb 27, 2023 at 07:12 PM
ContraFect Corporation (CFRX:NASDAQ) soared at $4.74, representing a gain of 52.9%. On Mon, Feb 27, 2023, CFRX:NASDAQ touched a New 2-Week Intraday High of $6.85. From Mon, Feb 13, 2023, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon, Feb 27, 2023 at $6.85 with a volume of 27M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- Lucira Health Inc. (LHDX:NASDAQ), 264.29%
- ContraFect Corporation (CFRX:NASDAQ), 52.9%
- Asset Entities Inc. (ASST:NASDAQ), 42.58%
- Concord Medical Services Holdings Limited (CCM:NYSE), 41.75%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Peak Bio Inc Com (PKBO:NASDAQ), 39.13%
- Troika Media Group Inc. (TRKA:NASDAQ), 32.13%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 30.55%
- Fisker Inc. Class A (FSR:NYSE), 30.28%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 25.6%